Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ) closed at $8.80 on October 23, 2026, down 0.68% on the day. The stock trades 53.1% below its 52-week high of $18.76 and 7,900.0% above its 52-week low of $0.110. Over the past year, it lost 36.0%. Aspire Biopharma Holdings, Inc. is part of the Health Care sector.
In 251 trading sessions since October 23, 2025, ASBP closed higher on 110 days (44%). Its best day was January 30, 2026 (+45.89%) and its worst was April 15, 2026 (-54.20%). The stock moved 10% or more in a single session 59 times. It opened at least 5% above the previous day's high 5 times.
Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspire's technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of "instant absorption" are to provide nearly instant treatment impact and also allows high dose absorption. Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs.
Find more stocks like ASBP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.